BRPI0706003B8 - seqüência geneticamente modificada do antígeno ama-1 de plasmodium vivax, proteína recombinante ama-1 e adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinante - Google Patents
seqüência geneticamente modificada do antígeno ama-1 de plasmodium vivax, proteína recombinante ama-1 e adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinanteInfo
- Publication number
- BRPI0706003B8 BRPI0706003B8 BRPI0706003A BRPI0706003A BRPI0706003B8 BR PI0706003 B8 BRPI0706003 B8 BR PI0706003B8 BR PI0706003 A BRPI0706003 A BR PI0706003A BR PI0706003 A BRPI0706003 A BR PI0706003A BR PI0706003 B8 BRPI0706003 B8 BR PI0706003B8
- Authority
- BR
- Brazil
- Prior art keywords
- ama
- antigen
- genetically modified
- recombinant
- protein
- Prior art date
Links
- 101100038180 Caenorhabditis briggsae rpb-1 gene Proteins 0.000 title abstract 8
- 239000000427 antigen Substances 0.000 title abstract 6
- 102000036639 antigens Human genes 0.000 title abstract 6
- 108091007433 antigens Proteins 0.000 title abstract 6
- 241000223810 Plasmodium vivax Species 0.000 title abstract 3
- 241000701161 unidentified adenovirus Species 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
seqüência geneticamente modificada do antígeno ama-1 de plasmodium vivax, proteína recombinante ama-1 e adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinante. a presente invenção diz respeito à construção de uma sequência genética modificada do antígeno ama-1 de plasmodium vivax, uma proteína recombinante codificada pela referida seqüência e um adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinante. a invenção é útil para a imunização de mamíferos contra malária.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0706003A BRPI0706003B8 (pt) | 2007-10-26 | 2007-10-26 | seqüência geneticamente modificada do antígeno ama-1 de plasmodium vivax, proteína recombinante ama-1 e adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinante |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0706003A BRPI0706003B8 (pt) | 2007-10-26 | 2007-10-26 | seqüência geneticamente modificada do antígeno ama-1 de plasmodium vivax, proteína recombinante ama-1 e adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinante |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0706003A2 BRPI0706003A2 (pt) | 2009-06-23 |
| BRPI0706003B1 BRPI0706003B1 (pt) | 2019-10-08 |
| BRPI0706003B8 true BRPI0706003B8 (pt) | 2021-05-25 |
Family
ID=40775293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0706003A BRPI0706003B8 (pt) | 2007-10-26 | 2007-10-26 | seqüência geneticamente modificada do antígeno ama-1 de plasmodium vivax, proteína recombinante ama-1 e adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinante |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0706003B8 (pt) |
-
2007
- 2007-10-26 BR BRPI0706003A patent/BRPI0706003B8/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0706003B1 (pt) | 2019-10-08 |
| BRPI0706003A2 (pt) | 2009-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119945T1 (el) | Φαρμακευτικη συνθεση ν-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδιου και χορηγηση αυτης | |
| BR112015027291A2 (pt) | entrega de imunossupressores que têm uma vida eficaz farmacodinâmica especificada e antígeno para a indução de tolerância imunológica | |
| EA201390383A1 (ru) | Стеклянная пластина | |
| EP2467157A4 (en) | MODIFICATION OF RECOMBINANT ADENOVIRES WITH IMMUNOGENOUS PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES | |
| BR112014008775A2 (pt) | camundongo de cadeia pesada de imunoglobulina restrita | |
| EP2483511A4 (en) | PREPARATION OF REDUCED CATALYST PDCS ON INCREASED REACTIVITY | |
| BR112012020432A2 (pt) | fibra óptica com maior resistência mecânica. | |
| ECSP13012724A (es) | Anticuerpos para el receptor de la barrera hematoencefálica de baja afinidad y sus usos | |
| EP2398498A4 (en) | FOR HUMAN OX40 SPECIFIC ANTIBODY MOLECULES | |
| BR112014020019A8 (pt) | vetores poxvirais recombinantes expressando tanto proteínas da raiva e ox40 e vacinas feitas a partir destes | |
| UY33407A (es) | Anticuerpos específicos del factor gdf8 humano | |
| BR112012000281A8 (pt) | Proteína quimérica | |
| CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
| EA201591057A1 (ru) | Штамм bifidobacterium animalis ssp. animalis | |
| BR112014001834A2 (pt) | biocontrole de nematoides | |
| BR112013002831A2 (pt) | anticorpos direcionados contra a il-17 | |
| UY31285A1 (es) | Vacunas | |
| PE20081687A1 (es) | Proteina de fusion | |
| BR112012007888A2 (pt) | "métodos de tratamento usando anticorpos anti-ldl oxidada". | |
| BR112013004582A2 (pt) | método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária | |
| BRPI0706003B8 (pt) | seqüência geneticamente modificada do antígeno ama-1 de plasmodium vivax, proteína recombinante ama-1 e adenovírus geneticamente modificado que expressa o antígeno ama-1 recombinante | |
| BRPI0705874B8 (pt) | seqüência geneticamente modificada do antígeno cs de plasmodium vivax, proteína recombinante cs e vírus geneticamente modificados que expressam o antígeno cs recombinante | |
| AR062145A1 (es) | Metoods y composiciones para aumentar el tropismo tisular de vectores adenovirales recombinantes | |
| BRPI0705990A2 (pt) | seqüência geneticamente modificada do antìgeno msp-1 de plasmodium vivax, proteìna recombinante msp-1 e adenovìrus geneticamente modificado que expressa o antìgeno msp-1 recombinante | |
| EP2571910A4 (en) | FUNCTIONAL MACROMONOMERS MANUFACTURED FROM AN ANHYDRIDE AND THROUGH FREE RADICAL |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B03H | Publication of an application: rectification [chapter 3.8 patent gazette] |
Free format text: REFERENTE A RPI 2007 DE 23/06/2009, QUANTO AO ITEM (72). |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
| B24B | Patent annual fee: requirement for complementing annual fee |
Free format text: COMPLEMENTAR A RETRIBUICAO DA(S) 12A ANUIDADE(S), DE ACORDO COM TABELA VIGENTE, REFERENTE A(S) GUIA(S) DE RECOLHIMENTO 29409161800356438. |
|
| B24E | Patent annual fee: resolution cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.2 NA RPI NO 2625 DE 27/04/2021. |
|
| B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/10/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |